164 จำนวนผู้เข้าชม |
08/08/2025
Metachromatic Leukodystrophy (MLD) is a rare genetic disorder that affects the central nervous system. It is caused by a deficiency of the enzyme arylsulfatase A, which is responsible for breaking down a substance in the nervous system known as sulfatides. Without this enzyme, sulfatides accumulate in the brain and spinal cord, leading to progressive nerve damage and loss of brain function.
MLD commonly occurs in children, though it can also affect adults. The disease is categorized into types based on the age at which symptoms appear.
MLD is caused by mutations in the ARSA gene , which encodes the arylsulfatase A enzyme. These mutations result in either insufficient production or a nonfunctional version of the enzyme, allowing sulfatides to build up and damage nerve cells in the brain and spinal cord.
The disorder is inherited in an autosomal recessive pattern, meaning a child must inherit one defective gene from each parent to develop the disease.
MLD is classified into three main types based on age of onset:
Symptoms typically begin between ages 2 and 4. Affected children may show delayed development, loss of motor skills, and speech difficulties.
This form appears in children aged 4 to 16. Symptoms progress gradually and may include difficulty with movement and coordination.
Symptoms begin in adulthood and progress more slowly. It is often harder to diagnose due to its milder and more variable presentation.
Symptoms vary by type but generally include:
Diagnosis involves genetic and biochemical testing, such as:
While there is currently no cure for MLD, treatments can help manage symptoms and improve quality of life:
Research is ongoing into enzyme replacement therapy and stem cell therapy, with some trials showing promise.
Patients may need care from a team of specialists, including neurologists, physical therapists, and psychologists, to address various aspects of the disease.
Psychological support and daily assistance from family members and caregivers are vital for maintaining quality of life.
Because MLD is a genetic disorder, prevention focuses on early genetic screening and counseling:
Families with a history of MLD can consult genetic specialists to evaluate risk and receive guidance on family planning.
Genetic testing for both partners can identify potential carriers of the mutated gene, helping to assess the risk of passing MLD to offspring.
MLD is a serious genetic condition affecting the nervous system in both children and adults. Although there is no definitive cure yet, early diagnosis, supportive treatments, and proper care can greatly improve a patient's quality of life. If you suspect that you or a loved one may have MLD, consult a healthcare professional for proper testing and care options.
© 2026 Siammerx Co., Ltd